Show simple item record

Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma

dc.contributor.authorBekaert, Etienne D.en_US
dc.contributor.authorAlaupovic, Petaren_US
dc.contributor.authorKnight-Gibson, Carolynen_US
dc.contributor.authorNorum, Robert A.en_US
dc.contributor.authorLaux, Matthew J.en_US
dc.contributor.authorAyrault-Jarrier, M.en_US
dc.date.accessioned2006-04-10T15:10:44Z
dc.date.available2006-04-10T15:10:44Z
dc.date.issued1992-06-05en_US
dc.identifier.citationBekaert, Etienne D., Alaupovic, Petar, Knight-Gibson, Carolyn, Norum, Robert A., Laux, Matthew J., Ayrault-Jarrier, M. (1992/06/05)."Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma." Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1126(1): 105-113. <http://hdl.handle.net/2027.42/29986>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T1X-48897DF-5K/2/18dae8bca6f2819c8451e0ef71306e12en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/29986
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1606170&dopt=citationen_US
dc.description.abstractHigh density lipoproteins (HDL) consist of a mixture of chemically and functionally distinct families of particles defined by their characteristic apolipoprotein (Apo) composition. The two major lipoprotein families are lipoprotein A-I (LP-A-I) and lipoprotein A-I : A-II (LP-A-I : A-II). This study describes the isolation of a third minor HDL family of particles referred to as lipoprotein A-II (LP-A-II) because it lacks ApoA-I and contains ApoA-II as its main or sole apolipoprotein constituent. Because ApoA-II is an integral protein constituent of three distinct lipoprotein families (LP-A-I : A-II, LP-A-II : B : C : D : E and LP-A-II), LP-A-II particles were isolated from whole plasma by sequential immunoaffinity chromatography on immunosorbers with antisera to ApoA-II, ApoB and ApoA-I, respectively. In normolipidemic subjects, the concentration of LP-A-II particles, based on ApoA-II content, is 4-18 mg/dl accounting for 5-20% of the total ApoA-II not associated with ApoB-containing lipoproteins. The lipid composition of LP-A-II particles is characterized by low percentages of triglycerides and cholesterol esters and a high percentage of phospholipids in comparison with lipid composition of LP-A-I and LP-A-I : A-II. The major part of LP-A-II particles contain ApoA-II as the sole apolipoprotein constituents; however, small subsets of LP-A-II particles may also contain ApoD and other minor apolipoproteins. The lipid/protein ratio of LP-A-II is higher than those of LP-A-I and LP-A-I : A-II. In homozygous ApoA-I and ApoA-I/ApoC-III deficiencies, LP-A-II particles are the only ApoA-containing high density lipoprotein with levels found to be within the same range (7-13 mg/dl) as those of normolipidemic subjects. However, in contrast to normal LP-A-II, their lipid composition is characterized by higher percentage of triglycerides and cholesterol esters and a lower percentage of phospholipids and their apolipoprotein composition by the presence of ApoC-peptides and ApoE in addition to ApoA-II and ApoD. These results show that LP-A-II particles are a minor HDL family and suggest that, in the absence of ApoA-I-containing lipoproteins, they become an efficient acceptor/donor of ApoC-peptides and ApoE required for a normal metabolism of triglyceride-rich lipoproteins. Their other possible functional roles in lipid transport remain to be established in future experiments.en_US
dc.format.extent857778 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleIsolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasmaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMaterials Science and Engineeringen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Health Center, The University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherLipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USAen_US
dc.contributor.affiliationotherLipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USAen_US
dc.contributor.affiliationotherLipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USAen_US
dc.contributor.affiliationotherDepartment of Dermatology, Henry Ford Hospital, Detroit, Mi, USAen_US
dc.contributor.affiliationotherINSERM U32, Hôpital Henri Mondor, Créteil, Franceen_US
dc.identifier.pmid1606170en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/29986/1/0000351.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0005-2760(92)90223-Ien_US
dc.identifier.sourceBiochimica et Biophysica Actaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.